Prevalence and Demographic Characteristics of Metabolic Syndrome in Iraqi Patients with Acute Coronary Syndrome

Zina S. AlDaggistany; Ihab S. Ahmed; Zuhair A. Al-Johar

doi:10.32007/jfacmedbagdad.6511951

Authors

Zina S. AlDaggistany Al Jihad Health Center for Family Medicine, Baghdad Health Directorate - Al-Karkh, MOH, Baghdad, Iraq
Ihab S. Ahmed Baghdad Teaching Hospital, Medical City, MOH, Baghdad, Iraq
Zuhair A. Al-Johar Department of Internal Medicine, College of Medicine, University of Baghdad, Baghdad, Iraq https://orcid.org/0000-0001-7533-0184

DOI:

https://doi.org/10.32007/jfacmedbagdad.6511951

Keywords:

Coronary, Demographics, Gender, Metabolic syndrome,

Abstract

Background: The demographic characteristics of Iraqi patients with metabolic syndrome (MS) and presenting with acute coronary syndrome (ACS) have been scarcely studied before. Aim of the study: To study the socio-demographic characteristics of a group of Iraqi patients with MS presenting with ACS. Patients and

Methods: A convenience sample of 150 cases presenting with ACS and admitted to the coronary care unit (CCU) of Al-Yarmouk Teaching Hospital in Baghdad from mid-January through July 2011 were included in the current cross-sectional study. The data needed for the study was collected through a direct interview to fill a questionnaire by all cases carried out by a consultant physician.

Results: Of all the 150 ACS cases included in the study, 69.3% had MS. The prevalence of MS among males was 63.8%, and among females was 78.6%. The most frequently seen age group was 50-59 years. Gender differences in MS patients were statistically significant regarding residence (Urban: 63.3% M, 84.1% F), educational level (illiteracy: 15% M, 52.3% F, high education: 25% M, 4.5% F), and employment (Employed: 50% M, 22.7% F). Males with MS and ACS had more myocardial infarction (MI) (80%) than unstable angina, compared to females (41% MI), with statistically significant associations.

Conclusion: The prevalence of MS in Iraqi ACS cases is high, and among them MI was significantly higher in males.

Received: July, 2022 Accepted: April 2023

Downloads

Download data is not yet available.

References

Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018; 20 (2): 12. https://doi.org/10.1007/s11906-018-0812-z.

Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539-53. https://doi.org/10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.

Guembe MJ, Fernandez-Lazaro CI, Sayon-Orea C, et al. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort. Cardiovasc Diabetol. 2020 Dec 3;19(1):195. https://doi.org/10.1186/s12933-020-01166-6.

Regufe VM, Pinto CMCB, Perez PMVHC. Metabolic syndrome in type 2 diabetic patients: a review of current evidence. Porto Biomed J. 2020;5(6):e101. https://doi.org/10.1097/j.pbj.0000000000000101.

Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843.

https://doi.org/10.1016/j.diabres.2019.107843.

Walle B, Reba K, Debela Y, Tadele K, Biadglegne F, Gutema H. Prevalence of Metabolic Syndrome and Factors Associated With It Among Adults of West Gojjam: A Community-Based Cross-Sectional Study. Diabetes Metab Syndr Obes. 2021;14:875-883.

https://doi.org/10.2147/DMSO.S295451.

Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23(5):469-80.

https://doi.org/10.1111/j.1464-5491.2006.01858.x.

Damiri B, Abualsoud MS, Samara AM, Abu Farsakh NA, Alefishat E, Al-Sharif Z, Albsoul-Younes AM, Jalambo MO. Metabolic syndrome among overweight and obese adults in Palestinian refugee camps. Diabetol Metab Syndr. 2018;10:34. https://doi.org/10.1186/s13098-018-0337-2.

Xu JJ, Song Y, Jiang P, Jiang L, Zhao XY, Gao Z, Li JX, Qiao SB, Gao RL, Yang YJ, Zhang Y, Xu B, Yuan JQ. Effects of metabolic syndrome on onset age and long-term outcomes in patients with acute coronary syndrome. World J Emerg Med. 2021;12(1):36-41.

https://doi.org/10.5847/wjem.j.1920-8642.2021.01.006.

Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuniga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122.

https://doi.org/10.1186/s12933-018-0762-4.

Al Suwaidi J, Higano ST, Holmes DR Jr, Lennon R, Lerman A. Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries. J Am Coll Cardiol. 2001;37(6):1523-8. https://doi.org/10.1016/S0735-1097(01)01212-8.

Newby DE, Grubb NR, Bradbury A. Cardiovascular disease. In: Colledge NR, Walker BR, Ralston SH, editors. Davidson's principles & practice of Medicine. 21st ed. International edition. China: Churchill Livingstone Elsevier; 2010. p. 590-592.

Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, et al. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J. 2007;28(20):2525-2538.

Zhu L, Spence C, Yang WJ, Ma GX. The IDF Definition Is Better Suited for Screening Metabolic Syndrome and Estimating Risks of Diabetes in Asian American Adults: Evidence from NHANES 2011-2016. J Clin Med. 2020;9(12):3871. https://doi.org/10.3390/jcm9123871.

Kassi E, Pervanidou P, Kaltsas G, Chrousos G. Metabolic syndrome: definitions and controversies. BMC Med. 2011;9:48. https://doi.org/10.1186/1741-7015-9-48

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-97. https://doi.org/10.1001/jama.285.19.2486.

Folsom AR, Kushi LH, Anderson KE, Mink PJ, Olson JE, Hong CP, et al. Associations of general and abdominal obesity with multiple health outcomes in older women: the Iowa Women's Health Study. Arch Intern Med. 2000;160(14):2117-28. https://doi.org/10.1001/archinte.160.14.2117.

Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, et al.; INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005; 366(9497):1640-9. https://doi.org/10.1016/S0140-6736(05)67663-5.

Côté M, Mauriège P, Bergeron J, Alméras N, Tremblay A, Lemieux I, et al. Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men. J Clin Endocrinol Metab. 2005;90(3):1434-9. https://doi.org/10.1210/jc.2004-1711.

Tchernof A, Lamarche B, Prud'Homme D, Nadeau A, Moorjani S, Labrie F, et al. The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Diabetes Care. 1996;19(6):629-37. https://doi.org/10.2337/diacare.19.6.629.

Fanta K, Daba FB, Asefa ET, Chelkeba L, Melaku T. Prevalence and Impact of Metabolic Syndrome on Short-Term Prognosis in Patients with Acute Coronary Syndrome: Prospective Cohort Study. Diabetes Metab Syndr Obes. 2021;14:3253-3262. https://doi.org/10.2147/DMSO.S320203.

Solymoss BC, Bourassa MG, Campeau L, Sniderman A, Marcil M, Lespérance J, et al. Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity. Am J Cardiol. 2004;93(2):159-64. https://doi.org/10.1016/j.amjcard.2003.09.032.

Levantesi G, Macchia A, Marfisi R, Franzosi MG, Maggioni AP, Nicolosi GL, et al.; GISSI-Prevenzione Investigators. Metabolic syndrome and risk of cardiovascular events after myocardial infarction. J Am Coll Cardiol. 2005;46(2):277-83. https://doi.org/10.1016/j.jacc.2005.03.062.

Clavijo LC, Pinto TL, Kuchulakanti PK, Torguson R, Chu WW, Satler LF, et al. Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications. Cardiovasc Revasc Med. 2006;7(1):7-11.

https://doi.org/10.1016/j.carrev.2005.10.007.

Al-Rasadi K, Sulaiman K, Panduranga P, Al-Zakwani I. Prevalence, characteristics, and in-hospital outcomes of metabolic syndrome among acute coronary syndrome patients from Oman. Angiology. 2011;62(5):381-9. https://doi.org/10.1177/0003319710382419.

Al Suwaidi J, Zubaid M, El-Menyar A, Rajvir S, Rashed R, Ridha M, et al. Prevalence of the Metabolic Syndrome in Patients with Acute Coronary Syndrome in Six Middle Eastern Countries. J Clin Hypertens (Greenwich). 2010; 12(11): 890-899. https://doi.org/10.1111/j.1751-7176.2010.00371.x.

Balkau B. Epidemiology of the metabolic syndrome and the RISC study. Eur Heart J. 2005;7 Suppl D:D6-9. https://doi.org/10.1093/eurheartj/sui022.

Espinola-Klein C, Rupprecht HJ, Bickel C, Post F, Genth-Zotz S, Lackner K, et al. for the AtheroGene Investigators. Impact of metabolic syndrome on atherosclerotic burden and cardiovascular prognosis. Am J Cardiol. 2007;99(12):1623-8. https://doi.org/10.1016/j.amjcard.2007.01.049.

Giampaoli S, Palmieri L, Donfrancesco C, Panico S, Vanuzzo D, Cesana G, et al. Research Group of the Progetto CUORE. The metabolic syndrome: aetiology, identifying criteria, pathologic anatomy, utility for CVD risk prediction - data from the Progetto CUORE. Eur Heart J. 2006;27 Suppl:852.

Alegria E, Cordero A, Laclaustra M, Grima A, Leo'n M, Casasnovas JA, et al. Prevalence of Metabolic Syndrome in the Spanish Working Population: MESYAS Registry. Rev Esp Cardiol. 2005;58(7):797-806. https://doi.org/10.1016/S1885-5857(06)60508-2.

Latre ML, Andrés EM, Cordero A, Pascual I, Vispe C, Laclaustra M, et al. Relationship between metabolic syndrome and ischemic heart disease mortality in Spain. Rev Esp Cardiol. 2009;62(12):1469-72. https://doi.org/10.1016/S1885-5857(09)73544-3.

Zaliūnas R, Slapikas R, Babarskiene R, Slapikiene B, Luksiene D, Milvidaite I, et al. The prevalence of the metabolic syndrome components and their combinations in men and women with acute ischemic syndromes. Medicina (Kaunas). 2008;44(7):521-8. https://doi.org/10.3390/medicina44070067.

Li FE, Zhang FL, Zhang P, Liu D, Liu HY, Guo ZN, Yang Y. Sex-based differences in and risk factors for metabolic syndrome in adults aged 40 years and above in Northeast China: Results from the cross-sectional China national stroke screening survey. BMJ Open. 2021;11(3):e038671. https://doi.org/10.1136/bmjopen-2020-038671.

Boulon C, Lafitte M, Richeboeuf V, Paviot B, Pradeau V, Coste P, et al. Prevalence of metabolic syndrome after acute coronary syndrome and its prognostic significance. Am J Cardiol. 2006; 98(11):1429-34. https://doi.org/10.1016/j.amjcard.2006.07.025.

Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the Third National Health and Nutrition Examination Survey. JAMA. 2002;287:356.

https://doi.org/10.1001/jama.287.3.356.

Al-Owaish RA. Descriptive epidemiology of acute myocardial infarction in Kuwait. Bull World Health Organ. 1983;61(3):509-16.

Al-Khezrachi AH. Pattern of Myocardial Infarction among Patients with Chronic Metabolic Syndrome [thesis]. Baghdad (IQ): College of MedicineUniversity of Baghdad; 2005.

Kuo WC, Bratzke LC, Oakley LD, Kuo F, Wang H, Brown RL. The association between psychological stress and metabolic syndrome: A systematic review and meta-analysis. Obes Rev. 2019;20(11):1651-1664. https://doi.org/10.1111/obr.12915